The 90 kDa ribosomal S6 kinase (RSK) household of proteins is a gaggle of extremely conserved Ser/Thr kinases that regulate various mobile processes, resembling cell progress, cell motility, cell survival and cell proliferation. RSKs are downstream effectors of the Ras-extramobile signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signalling cascade.
Important advances within the subject of RSK and ERK/MAPK signalling have occurred prior to now few years, together with organic insights and the invention of novel substrates and new RSK regulatory mechanisms. Collectively, these information broaden the present fashions of RSK signalling and spotlight potential instructions of analysis in RSK-mediated survival, progress, proliferation and migration.
Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the research of heredity and evolution.
This assessment describes new developments within the research of transgenerational epigenetic inheritance, a element of epigenetics. We begin by analyzing the essential ideas of the sector and the mechanisms that underlie epigenetic inheritance. We current a complete assessment of transgenerational mobile epigenetic inheritance amongst completely different taxa within the type of a desk, and focus on the information contained therein.
The evaluation of those information exhibits that epigenetic inheritance is ubiquitous and suggests strains of analysis that transcend current approaches to the topic. We conclude by exploring a number of the penalties of epigenetic inheritance for the research of evolution, whereas additionally pointing to the significance of recognizing and understanding epigenetic inheritance for sensible and theoretical points in biology.
Rules for characterizing the potential human well being results from publicity to nanomaterials: components of a screening technique.
The speedy proliferation of many various engineered nanomaterials (outlined as supplies designed and produced to have structural options with no less than one dimension of 100 nanometers or much less) presents a dilemma to regulators concerning hazard identification.
The Worldwide Life Sciences Institute Analysis Basis/Danger Science Institute convened an professional working group to develop a screening technique for the hazard identification of engineered nanomaterials. The working group report presents the weather of a screening technique somewhat than an in depth testing protocol. Primarily based on an analysis of the restricted information at the moment accessible, the report presents a broad information gathering technique relevant to this early stage within the improvement of a threat evaluation course of for nanomaterials.
Oral, dermal, inhalation, and injection routes of publicity are included recognizing that, relying on use patterns, publicity to nanomaterials might happen by any of those routes. The three key components of the toxicity screening technique are: Physicochemical Traits, In Vitro Assays (mobile and non-mobile), and In Vivo Assays. There’s a robust probability that organic exercise of nanoparticles will rely on physicochemical parameters not routinely thought-about in toxicity screening research.
Physicochemical properties which may be essential in understanding the poisonous results of take a look at supplies embody particle measurement and measurement distribution, agglomeration state, form, crystal construction, chemical composition, floor space, floor chemistry, floor cost, and porosity. In vitro strategies permit particular organic and mechanistic pathways to be remoted and examined underneath managed circumstances, in methods that aren’t possible in in vivo exams.
Checks are prompt for portal-of-entry toxicity for lungs, pores and skin, and the mucosal membranes, and goal organ toxicity for endothelium, blood, spleen, liver, nervous system, coronary heart, and kidney. Non-mobile evaluation of nanoparticle sturdiness, protein interactions, complement activation, and pro-oxidant exercise can also be thought-about.
Tier 1 in vivo assays are proposed for pulmonary, oral, pores and skin and injection exposures, and Tier 2 evaluations for pulmonary exposures are additionally proposed. Tier 1 evaluations embody markers of irritation, oxidant stress, and cell proliferation in portal-of-entry and chosen distant organs and tissues.
Tier 2 evaluations for pulmonary exposures may embody deposition, translocation, and toxicokinetics and biopersistence research; results of a number of exposures; potential results on the reproductive system, placenta, and fetus; different animal fashions; and mechanistic research.
Subtypes of medulloblastoma have distinct developmental origins.
Medulloblastoma encompasses a group of clinically and molecularly various tumour subtypes that collectively comprise the most typical malignant childhood mind tumour. These tumours are thought to come up throughout the cerebellum, with roughly 25% originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Sonic Hedgehog pathway (hereafter, SHH subtype).
The pathological processes that drive heterogeneity among the many different medulloblastoma subtypes are usually not recognized, hindering the event of a lot wanted new therapies. Right here we offer proof {that a} discrete subtype of medulloblastoma that incorporates activating mutations within the WNT pathway effector CTNNB1 (hereafter, WNT subtype) arises exterior the cerebellum from cells of the dorsal brainstem.
We discovered that genes marking human WNT-subtype medulloblastomas are extra continuously expressed within the decrease rhombic lip (LRL) and embryonic dorsal brainstem than within the higher rhombic lip (URL) and growing cerebellum. Magnetic resonance imaging (MRI) and intra-operative studies confirmed that human WNT-subtype tumours infiltrate the dorsal brainstem, whereas SHH-subtype tumours are situated throughout the cerebellar hemispheres.
Activating mutations in Ctnnb1 had little influence on progenitor cell populations within the cerebellum, however induced the irregular accumulation of cells on the embryonic dorsal brainstem which included aberrantly proliferating Zic1(+) precursor cells.
These lesions endured in all mutant grownup mice; furthermore, in 15% of circumstances wherein Tp53 was concurrently deleted, they progressed to type medulloblastomas that recapitulated the anatomy and gene expression profiles of human WNT-subtype medulloblastoma.
We offer the primary proof, to our information, that subtypes of medulloblastoma have distinct mobile origins. Our information present an evidence for the marked molecular and medical variations between SHH- and WNT-subtype medulloblastomas and have profound implications for future analysis and therapy of this essential childhood most cancers.
A complete classification system for lipids.
Lipids are produced, transported, and acknowledged by the concerted actions of quite a few enzymes, binding proteins, and receptors. A complete evaluation of lipid molecules, “lipidomics,” within the context of genomics and proteomics is essential to understanding mobile physiology and pathology; consequently, lipid biology has change into a serious analysis goal of the postgenomic revolution and programs biology.
To facilitate worldwide communication about lipids, a complete classification of lipids with a standard platform that’s appropriate with informatics necessities has been developed to take care of the large quantities of information that might be generated by our lipid neighborhood.
As an preliminary step on this improvement, we divide lipids into eight classes (fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides) containing distinct courses and subclasses of molecules, devise a standard method of representing the chemical constructions of particular person lipids and their derivatives, and supply a 12 digit identifier for every distinctive lipid molecule.
 CD134 |
|||
| MO134CFB(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134CFB(V25) | ImmunoStep | 25 ug | EUR 60 |
CD134 |
|||
| MO134F(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134F(V25) | ImmunoStep | 25 ug | EUR 60 |
CD134 |
|||
| MO134F(V500) | ImmunoStep | 500 ug | EUR 60 |
CD134 |
|||
| MO134PE(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134PE(V25) | ImmunoStep | 25 ug | EUR 60 |
CD134 |
|||
| MO134PP(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134PP(V25) | ImmunoStep | 25 ug | EUR 60 |
CD134 |
|||
| MO134PP5.5(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134PP5.5(V25) | ImmunoStep | 25 ug | EUR 60 |
CD134 |
|||
| MO134PU(V100) | ImmunoStep | 100 ug | EUR 60 |
CD134 |
|||
| MO134PU(V500) | ImmunoStep | 500 ug | EUR 60 |
 CD134 Antibody |
|||
| abx140447-100tests | Abbexa | 100 tests | EUR 577.2 |
CD134 Antibody |
|||
| abx140448-100tests | Abbexa | 100 tests | EUR 510 |
CD134 Antibody |
|||
| 45130-100ul | SAB | 100ul | EUR 302.4 |
CD134 Antibody |
|||
| 45130-50ul | SAB | 50ul | EUR 224.4 |
CD134 Antibody |
|||
| ABD7751 | Lifescience Market | 100 ug | EUR 525.6 |
 OX40/CD134/TNFRSF4 |
|||
| MO47051 | Neuromics | 100 ul | EUR 418.8 |
) CD134 Antibody (FITC) |
|||
| 20-abx200691 | Abbexa |
|
|
 OX40 Antibody / CD134 |
|||
| R20332-0.1ML | NSJ Bioreagents | 100ul | EUR 347.65 |
|
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4), also called OX40 and CD134 is the receptor for TNFSF4/OX40L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity. Acts as a receptor for human herpesvirus 6B/HHV-6B. [UniProt] |
|||
OX40 Antibody / CD134 |
|||
| R31251 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Tumor necrosis factor receptor superfamilymember 4 (TNR4), also known as OX40, ACT35 and CD134, is a cell surface glycoprotein. OX40 is the primary receptor for feline immunodeficiency virus. Expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development. |
|||
OX40 Antibody / CD134 |
|||
| R31252 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Tumor necrosis factor receptor superfamily, member4, also known as ACT35 or CD134 is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. OX40 was mapped to 1p36 by fluorescence in situ hybridization. CD134 is the primary receptor for feline immunodeficiency virus. OX40 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development. |
|||
OX40 Antibody / CD134 |
|||
| R31253 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Tumor necrosis factor receptor superfamily, member4, also known as ACT35 or CD134 is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. CD134 was mapped to 1p36 by fluorescence in situ hybridization. CD134 is the primary receptor for feline immunodeficiency virus. CD134 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development. |
|||
OX40 Antibody / CD134 |
|||
| R32104 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: OX40 (CD134) and its binding partner, OX40L (CD252), are members of the tumor necrosis factor receptor/tumor necrosis factor superfamily, is known to break an existing state of tolerance in malignancies, leading to a reactivation of antitumor immunity. The interaction between the proteins plays an important role in antigen-specific T-cell expansion and survival. OX40 and OX40L also regulate cytokine production from T cells, antigen-presenting cells, natural killer cells, and natural killer T cells, and modulate cytokine receptor signaling. In line with these important modulatory functions, OX40-OX40L interactions have been found to play a central role in the development of multiple inflammatory and autoimmune diseases, making them attractive candidates for intervention in the clinic. Conversely, stimulating OX40 has shown it to be a candidate for therapeutic immunization strategies for cancer and infectious disease. |
|||
 Cd134 Antibody / Ox40 |
|||
| RQ4380 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Tumor necrosis factor receptor superfamily, member 4, also known as ACT35 or CD134, is a cell surface glycoprotein that was discovered through the production of a monoclonal antibody raised against the HUT-102 cell line. It belongs to the tumor necrosis factor receptor superfamily. CD134 was mapped to 1p36 by fluorescence in situ hybridization. It is the primary receptor for feline immunodeficiency virus. And CD134 expression can promote viral binding and renders cells permissive for viral entry, productive infection, and syncytium formation. Stimulating the receptor can improve the response to a powerful virus vector and may be useful in vaccine development. |
|||
OX40 Antibody / CD134 |
|||
| V7534-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V7534-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V7534IHC-7ML | NSJ Bioreagents | 7 ml | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V7534SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8349-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: CD134 is a type I integral membrane protein. This receptor is expressed on activated CD4+and CD8+T cells and B cells. The CD134 binds to CD134 ligand (CD252) to provide a costimulatory signal that is independent of CD28. CD134 is involved in coordinating CD4 T cell selection, migration and cytokine differentiation in T helper (Th)1 and Th2 cells. CD134 is also involved in the stimulation of T cells, T dependent humoral response and generation of optimal CD4+ T cell responses in vivo and in vitro. CD134 is expressed on activated CD4+ T lymphocytes, and its ligand, CD134L, is found preferentially on activated B cells. Engagement of CD134 with its ligand, CD134L, delivers a strong costimulatory signal to effector T cells. |
|||
OX40 Antibody / CD134 |
|||
| V8349-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: CD134 is a type I integral membrane protein. This receptor is expressed on activated CD4+and CD8+T cells and B cells. The CD134 binds to CD134 ligand (CD252) to provide a costimulatory signal that is independent of CD28. CD134 is involved in coordinating CD4 T cell selection, migration and cytokine differentiation in T helper (Th)1 and Th2 cells. CD134 is also involved in the stimulation of T cells, T dependent humoral response and generation of optimal CD4+ T cell responses in vivo and in vitro. CD134 is expressed on activated CD4+ T lymphocytes, and its ligand, CD134L, is found preferentially on activated B cells. Engagement of CD134 with its ligand, CD134L, delivers a strong costimulatory signal to effector T cells. |
|||
OX40 Antibody / CD134 |
|||
| V8349SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: CD134 is a type I integral membrane protein. This receptor is expressed on activated CD4+and CD8+T cells and B cells. The CD134 binds to CD134 ligand (CD252) to provide a costimulatory signal that is independent of CD28. CD134 is involved in coordinating CD4 T cell selection, migration and cytokine differentiation in T helper (Th)1 and Th2 cells. CD134 is also involved in the stimulation of T cells, T dependent humoral response and generation of optimal CD4+ T cell responses in vivo and in vitro. CD134 is expressed on activated CD4+ T lymphocytes, and its ligand, CD134L, is found preferentially on activated B cells. Engagement of CD134 with its ligand, CD134L, delivers a strong costimulatory signal to effector T cells. |
|||
OX40 Antibody / CD134 |
|||
| V8400-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134.OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells.OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8400-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134.OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells.OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8400SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134.OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells.OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8480-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8480-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8480SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8563-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8563-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
OX40 Antibody / CD134 |
|||
| V8563SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This MAb recognizes a protein of 43kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts. It functions as a T cell co-stimulatory receptor when bound by OX40 Ligand / TNFSF4 that is expressed by antigen presenting cells. OX40 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells. OX40 is upregulated at the sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions. |
|||
) CD134 Antibody (Biotin) |
|||
| 20-abx200689 | Abbexa |
|
|
 TNFRSF4/CD134 Antibody |
|||
| DF7751 | Affbiotech | 200ul | EUR 420 |
 CD134 Blocking Peptide |
|||
| DF7751-BP | Affbiotech | 1mg | EUR 234 |
TNFRSF4/CD134 Antibody |
|||
| DF7812 | Affbiotech | 200ul | EUR 420 |
CD134 Blocking Peptide |
|||
| 20-abx161491 | Abbexa |
|
|
CD134 Blocking Peptide |
|||
| 20-abx161492 | Abbexa |
|
|
 CD134 Recombinant Protein |
|||
| 96-571 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5. |
|||
CD134 Recombinant Protein |
|||
| 96-572 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5. |
|||
 Anti-Hu CD134 PE |
|||
| 1P-152-T025 | ExBio | 25 tests | EUR 168 |
Anti-Hu CD134 PE |
|||
| 1P-152-T100 | ExBio | 100 tests | EUR 288 |
 Anti-Hu CD134 APC |
|||
| 1A-152-T100 | ExBio | 100 tests | EUR 288 |
 Anti-Hu CD134 FITC |
|||
| 1F-152-T100 | ExBio | 100 tests | EUR 244.8 |
, Fc fusion) OX40 (CD134), Fc fusion |
|||
| 71175 | BPS Bioscience | 100 µg | EUR 320 |
|
Description: Human secreted OX40, Fc fusion protein,_x000D_also known as Tumor Necrosis Factor_x000D_Receptor Superfamily Member 4,_x000D_TNFRSF4, and CD134, GenBank_x000D_Accession No. NM_003327, a.a. 29-216_x000D_expressed in a HEK293 cell expression_x000D_system. MW = 46.8 kDa (monomer). This_x000D_protein runs at a higher MW by SDS-PAGE_x000D_due to glycosylation. |
|||
 Anti-Hu CD134 Purified |
|||
| 11-152-C025 | ExBio | 0.025 mg | EUR 118.8 |
Anti-Hu CD134 Purified |
|||
| 11-152-C100 | ExBio | 0.1 mg | EUR 189.6 |
 anti- CD134/OX40 antibody |
|||
| FNab01422 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against CD134/OX40 |
|||
 CD134 [OX40] Recombinant Protein |
|||
| 90-407 | ProSci | 50 ug | EUR 619.8 |
|
Description: CD134 (OX40) is a T cell activation antigen structurally belonging to a lymphocyte-specific subgroup of the nerve growth factor and tumor necrosis factor receptor superfamily, which also includes the T cell antigen CD27, B cell antigen CD40, FAS antigen and the T cell activation antigen 4-1BB. The human CD134 protein is expressed only on activated CD4 + T blasts, and its ligand has been identified as gp34. Interactions between CD134 and its ligand in vivo are necessary for the differentiation of activated B cells into highly immunoglobulin-producing cells, however not involved in other pathways of antigen-driven differentiation of B cells such as development of memory cells in the germinal centers. In addition, the CD134 and gp34 system directly mediate adhesion of activated T cells to vascular endothelial cells, and contribute to growth stimulation of the virus-infected T cells. |
|||
CD134 [OX40] Recombinant Protein |
|||
| 90-408 | ProSci | 25 ug | EUR 588.3 |
|
Description: CD134 (OX40) is a T cell activation antigen structurally belonging to a lymphocyte-specific subgroup of the nerve growth factor and tumor necrosis factor receptor superfamily, which also includes the T cell antigen CD27, B cell antigen CD40, FAS antigen and the T cell activation antigen 4-1BB. The human CD134 protein is expressed only on activated CD4+ T blasts, and its ligand has been identified as gp34. Interactions between CD134 and its ligand in vivo are necessary for the differentiation of activated B cells into highly immunoglobulin-producing cells, however not involved in other pathways of antigen-driven differentiation of B cells such as development of memory cells in the germinal centers. In addition, the CD134 and gp34 system directly mediate adhesion of activated T cells to vascular endothelial cells, and contribute to growth stimulation of the virus-infected T cells. |
|||
 ELISA Kit) OX40/CD134 (Human) ELISA Kit |
|||
| K4173-100 | Biovision | each | EUR 874.8 |
 Polyclonal TNFRSF4 / CD134 / OX40 Antibody |
|||
| APR03227G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TNFRSF4 / CD134 / OX40 . This antibody is tested and proven to work in the following applications: |
|||
 OX40 / TNFRSF4 / CD134 Recombinant Protein |
|||
| 11-498 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5. |
|||
, Biotin-labeled, His-tag) OX40 (CD134), Biotin-labeled, His-tag |
|||
| 71310-1 | BPS Bioscience | 25 µg | EUR 295 |
|
Description: Human secreted OX40, also known as_x000D_CD134, Tumor Necrosis Factor Receptor_x000D_Superfamily Member 4, and TNFRSF4,_x000D_GenBank Accession No. NM_003327, a.a._x000D_29-216 with C-terminal Avitag™ and Histag,_x000D_expressed in a HEK293 cell expression_x000D_system. This protein is enzymatically biotinlabeled_x000D_using Avitag™ technology. MW =_x000D_23.6 kDa (monomer). This protein runs at a_x000D_higher MW by SDS-PAGE due to_x000D_glycosylation. Biotinylation was confirmed to_x000D_be >90%. |
|||
OX40 (CD134), Biotin-labeled, His-tag |
|||
| 71310-2 | BPS Bioscience | 50 µg | EUR 435 |
|
Description: Human secreted OX40, also known as_x000D_CD134, Tumor Necrosis Factor Receptor_x000D_Superfamily Member 4, and TNFRSF4,_x000D_GenBank Accession No. NM_003327, a.a._x000D_29-216 with C-terminal Avitag™ and Histag,_x000D_expressed in a HEK293 cell expression_x000D_system. This protein is enzymatically biotinlabeled_x000D_using Avitag™ technology. MW =_x000D_23.6 kDa (monomer). This protein runs at a_x000D_higher MW by SDS-PAGE due to_x000D_glycosylation. Biotinylation was confirmed to_x000D_be >90%. |
|||
, Rabbit Monoclonal Antibody) Anti-OX40 (CD134), Rabbit Monoclonal Antibody |
|||
| A1827-50 | Biovision | each | Ask for price |
 Marmoset OX40 / TNFRSF4 / CD134 Recombinant Protein |
|||
| 11-511 | ProSci | 0.1 mg | EUR 789.9 |
|
Description: Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5. |
|||
) Recombinant Mouse OX40/TNFRSF4/CD134 (C-Fc) |
|||
| CK52-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (C-Fc) |
|||
| CK52-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (C-Fc) |
|||
| CK52-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (C-Fc) |
|||
| CK52-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
) Recombinant Mouse OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK53-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK53-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK53-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK53-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
) Recombinant Human OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK59-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK59-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK59-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (N-Fc) |
|||
| CK59-50ug | Novoprotein | 50ug | EUR 406.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
) Recombinant Human OX40/TNFRSF4/CD134 (C-6His) |
|||
| CK60-10ug | Novoprotein | 10ug | EUR 132 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (C-6His) |
|||
| CK60-1mg | Novoprotein | 1mg | EUR 2008.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (C-6His) |
|||
| CK60-500ug | Novoprotein | 500ug | EUR 1423.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Human OX40/TNFRSF4/CD134 (C-6His) |
|||
| CK60-50ug | Novoprotein | 50ug | EUR 278.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
 Rat cluster Of differentiation,CD134 ELISA kit |
|||
| E02C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat cluster Of differentiation,CD134 ELISA kit |
|||
| E02C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat cluster Of differentiation,CD134 ELISA kit |
|||
| E02C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Dog cluster Of differentiation,CD134 ELISA kit |
|||
| E08C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Canine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog cluster Of differentiation,CD134 ELISA kit |
|||
| E08C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Canine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog cluster Of differentiation,CD134 ELISA kit |
|||
| E08C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Canine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Pig cluster Of differentiation,CD134 ELISA kit |
|||
| E07C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig cluster Of differentiation,CD134 ELISA kit |
|||
| E07C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig cluster Of differentiation,CD134 ELISA kit |
|||
| E07C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Goat cluster Of differentiation,CD134 ELISA kit |
|||
| E06C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat cluster Of differentiation,CD134 ELISA kit |
|||
| E06C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat cluster Of differentiation,CD134 ELISA kit |
|||
| E06C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Mouse cluster Of differentiation,CD134 ELISA kit |
|||
| E03C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse cluster Of differentiation,CD134 ELISA kit |
|||
| E03C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse cluster Of differentiation,CD134 ELISA kit |
|||
| E03C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Human cluster Of differentiation,CD134 ELISA kit |
|||
| E01C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human cluster Of differentiation,CD134 ELISA kit |
|||
| E01C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human cluster Of differentiation,CD134 ELISA kit |
|||
| E01C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Rabbit cluster Of differentiation,CD134 ELISA kit |
|||
| E04C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit cluster Of differentiation,CD134 ELISA kit |
|||
| E04C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit cluster Of differentiation,CD134 ELISA kit |
|||
| E04C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Monkey cluster Of differentiation,CD134 ELISA kit |
|||
| E09C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey cluster Of differentiation,CD134 ELISA kit |
|||
| E09C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey cluster Of differentiation,CD134 ELISA kit |
|||
| E09C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Human CellExp? TNFRSF4/OX40 /CD134, human recombinant |
|||
| 7438-10 | Biovision | each | EUR 366 |
) Recombinant Cynomolgus OX40/TNFRSF4/CD134 (C-6His) |
|||
| CB17-10ug | Novoprotein | 10ug | EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus OX40/TNFRSF4/CD134 (C-6His) |
|||
| CB17-1mg | Novoprotein | 1mg | EUR 2983.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus OX40/TNFRSF4/CD134 (C-6His) |
|||
| CB17-500ug | Novoprotein | 500ug | EUR 2106 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Cynomolgus OX40/TNFRSF4/CD134 (C-6His) |
|||
| CB17-50ug | Novoprotein | 50ug | EUR 595.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
) Polyclonal TNFRSF4 / CD134 / OX40 Antibody (N-Terminus) |
|||
| APR03222G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TNFRSF4 / CD134 / OX40 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
 Human CellExp? OX40 / TNFRSF4 / CD134, rabbit recombinant |
|||
| P1085-10 | Biovision | each | EUR 170.4 |
Human CellExp? OX40 / TNFRSF4 / CD134, rabbit recombinant |
|||
| P1085-50 | Biovision | each | EUR 601.2 |
 Guinea pig cluster Of differentiation,CD134 ELISA kit |
|||
| E05C2460-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig cluster Of differentiation,CD134 ELISA kit |
|||
| E05C2460-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig cluster Of differentiation,CD134 ELISA kit |
|||
| E05C2460-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig cluster Of differentiation,CD134 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Rabbit Monoclonal Antibody, Clone#RM313) Anti-OX40 (CD134) Rabbit Monoclonal Antibody, Clone#RM313 |
|||
| M02495-1 | BosterBio | 100uL | EUR 462 |
|
Description: Anti-OX40 (CD134) Rabbit Monoclonal Antibody, Clone#RM313 tested in WB, IHC, reactive to Human |
|||
 Human CellExp? OX40 / TNFRSF4 / CD134, Fc Tag, rat recombinant |
|||
| P1151-10 | Biovision | each | EUR 183.6 |
Human CellExp? OX40 / TNFRSF4 / CD134, Fc Tag, rat recombinant |
|||
| P1151-50 | Biovision | each | EUR 574.8 |
 Antibody) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| 20-abx200695 | Abbexa |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx231422-100ug | Abbexa | 100 ug | EUR 661.2 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| 20-abx219033 | Abbexa |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx139929-01mg | Abbexa | 0.1 mg | EUR 427.2 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| 20-abx121781 | Abbexa |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| 20-abx121782 | Abbexa |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx413055-01mg | Abbexa | 0.1 mg | EUR 526.8 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx415451-01mg | Abbexa | 0.1 mg | EUR 526.8 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx414352-01mg | Abbexa | 0.1 mg | EUR 543.6 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody |
|||
| abx413051-025mg | Abbexa | 0.25 mg | EUR 678 |
 (mouse IgG2b)) Mouse Monoclonal Anti-Rat CD134, PE (Clone OX40) (mouse IgG2b) |
|||
| RCD134-PE | Alpha Diagnostics | 100 tests | EUR 562.8 |
 Monoclonal antibody, clone OX-86) Rat Anti-Mouse OX40 (CD134) Monoclonal antibody, clone OX-86 |
|||
| CABT-L4372-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse OX40 (CD134) Monoclonal antibody, clone OX-86 |
|||
| CABT-L4372-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
 (mouse IgG2b)) Mouse Monoclonal Anti-Rat CD134, FITC (Clone OX40) (mouse IgG2b) |
|||
| RCD134-F | Alpha Diagnostics | 100 tests | EUR 562.8 |
 (mouse IgG2b)) Mouse Monoclonal Anti-Rat CD134, Biotin (Clone OX40) (mouse IgG2b) |
|||
| RCD134-B | Alpha Diagnostics | 100 tests | EUR 562.8 |
 (mouse IgG2b)) Mouse Monoclonal Anti-Rat CD134, Purified (Clone OX40) (mouse IgG2b) |
|||
| RCD134-M | Alpha Diagnostics | 100 tests | EUR 578.4 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-1mg |
|||
| QP6816-ec-1mg | EnQuireBio | 1mg | EUR 2763.6 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-10ug |
|||
| QP6816-ec-10ug | EnQuireBio | 10ug | EUR 326.4 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-50ug |
|||
| QP6816-ec-50ug | EnQuireBio | 50ug | EUR 434.4 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-100ug |
|||
| QP6816-ec-100ug | EnQuireBio | 100ug | EUR 685.2 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-200ug |
|||
| QP6816-ec-200ug | EnQuireBio | 200ug | EUR 1077.6 |
 Recombinant Mouse TNFRSF4/ OX40/ CD134 Protein, His-SUMO, E.coli-500ug |
|||
| QP6816-ec-500ug | EnQuireBio | 500ug | EUR 1816.8 |
 Antibody (PE)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (PE) |
|||
| 20-abx200692 | Abbexa |
|
|
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (PE) |
|||
| abx139930-100tests | Abbexa | 100 tests | EUR 577.2 |
 Antibody (APC)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (APC) |
|||
| 20-abx200688 | Abbexa |
|
|
 Antibody (FITC)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (FITC) |
|||
| abx413053-50ug | Abbexa | 50 ug | EUR 410.4 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (FITC) |
|||
| abx413054-05mg | Abbexa | 0.5 mg | EUR 861.6 |
 Antibody (RPE)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (RPE) |
|||
| abx413056-100tests | Abbexa | 100 tests | EUR 710.4 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (FITC) |
|||
| abx415450-01mg | Abbexa | 0.1 mg | EUR 610.8 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (FITC) |
|||
| abx414351-01mg | Abbexa | 0.1 mg | EUR 777.6 |
Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (FITC) |
|||
| abx413052-01mg | Abbexa | 0.1 mg | EUR 610.8 |
 Antibody (PerCP)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (PerCP) |
|||
| 20-abx200693 | Abbexa |
|
|
(rat IgG1)) Rat Monoclonal Anti-Mouse CD134, PE (Clone OX-86)(rat IgG1) |
|||
| MCD134-PE | Alpha Diagnostics | 100 tests | EUR 562.8 |
(rat IgG1)) Rat Monoclonal Anti-Mouse CD134, FITC (Clone OX-86)(rat IgG1) |
|||
| MCD134-F | Alpha Diagnostics | 100 tests | EUR 562.8 |
(rat IgG1)) Rat Monoclonal Anti-Mouse CD134, Biotin (Clone OX-86)(rat IgG1) |
|||
| MCD134-B | Alpha Diagnostics | 100 tests | EUR 562.8 |
(rat IgG1)) Rat Monoclonal Anti-Mouse CD134, Purified (Clone OX-86)(rat IgG1) |
|||
| MCD134-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
 Antibody (CF-Blue)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (CF-Blue) |
|||
| 20-abx200690 | Abbexa |
|
|
 Antibody (PerCP-Cy5.5)) Tumor Necrosis Factor Receptor Superfamily Member 4 (CD134) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200694 | Abbexa |
|
|
 ELISA Kit) Rat Tumor Necrosis Factor Receptor Superfamily Member 4 / CD134 (TNFRSF4) ELISA Kit |
|||
| abx519604-96tests | Abbexa | 96 tests | EUR 801.6 |
 ELISA Kit) Human Tumor Necrosis Factor Receptor Superfamily Member 4 / CD134 (TNFRSF4) ELISA Kit |
|||
| abx252496-96tests | Abbexa | 96 tests | EUR 764.4 |
 ELISA Kit) Mouse Tumor Necrosis Factor Receptor Superfamily Member 4 / CD134 (TNFRSF4) ELISA Kit |
|||
| 20-abx154775 | Abbexa |
|
|
Human Tumor Necrosis Factor Receptor Superfamily Member 4 / CD134 (TNFRSF4) ELISA Kit |
|||
| abx576753-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse Tumor Necrosis Factor Receptor Superfamily Member 4 / CD134 (TNFRSF4) ELISA Kit |
|||
| abx575693-96tests | Abbexa | 96 tests | EUR 801.6 |
 anti-CD134 / OX40 |
|||
| YF-PA24917 | Abfrontier | 50 ul | EUR 400.8 |
|
Description: Mouse polyclonal to CD134 / OX40 |
|||
 Anti-CD134/OX40 antibody |
|||
| PAab01422 | Lifescience Market | 100 ug | EUR 494.4 |
 Anti-CD134 Monoclonal Antibody |
|||
| M02495 | BosterBio | 100ug | EUR 476.4 |
|
Description: Rabbit Monoclonal CD134 Antibody. Validated in WB and tested in Human. |
|||
 Anti-CD134/OX40/Tnfrsf4 Antibody |
|||
| A02495 | BosterBio | 100ug/vial | EUR 352.8 |
 Anti-CD134/OX40/TNFRSF4 Antibody |
|||
| PB9898 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-CD134/OX40/TNFRSF4 Antibody |
|||
| PA2136-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CD134/OX40/TNFRSF4 Antibody |
|||
| PA2136-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-CD134/OX40/TNFRSF4 Antibody |
|||
| PA2136-3 | BosterBio | 100ug/vial | EUR 352.8 |
 Anti-CD134 / OX40L receptor Antibody |
|||
| STJ503339 | St John's Laboratory | 100 µg | EUR 571.2 |
 Anti-CD134 / OX40L receptor Antibody BIOTIN |
|||
| STJ503340 | St John's Laboratory | 100 µg | EUR 703.2 |
 Anti-CD134 / OX40L receptor Antibody FITC |
|||
| STJ503341 | St John's Laboratory | 100 µg | EUR 703.2 |
 CD103/ CD22/ CD20 |
|||
| 103F22PE20PP2-50T | ImmunoStep | 50 test | EUR 840 |
 CD3/CD16+56/CD45/CD19 |
|||
| 3F11656PE45PC319A3-50T | ImmunoStep | 50 test | EUR 1020.96 |
) CD157/ CD45/ CD64 (HPN) |
|||
| 157PE45PP264A-25T | ImmunoStep | 50 test | EUR 769.8 |
CD157/ CD45/ CD64 (HPN) |
|||
| 157PE45PP264A-50T | ImmunoStep | 50 test | EUR 1144.2 |
CD157/ CD45/ CD64 (HPN) |
|||
| PNH(V25) | ImmunoStep | 25 test | EUR 785.4 |
CD157/ CD45/ CD64 (HPN) |
|||
| PNH(V50) | ImmunoStep | 50 test | EUR 1159.8 |
The lipid classification scheme is chemically based mostly and pushed by the distinct hydrophobic and hydrophilic components that compose the lipid. This structured vocabulary will facilitate the systematization of lipid biology and allow the cataloging of lipids and their properties in a means that’s appropriate with different macromolecular informationbases.